Vitiligo is a complex disease whose pathogenesis results from the interaction of genetic
components, metabolic factors linked to cellular oxidative stress, melanocyte adhesion to the …

Vitiligo is a common chronic autoimmune disorder characterized by skin and hair
depigmentation that affects 0.5%–2.0% of the global population. Vitiligo is associated with …

Background Vitiligo is an acquired skin disease with a worldwide prevalence of 0.5%–2%
and a tendency to involve both genders. Although the exact pathologic mechanism is …

Little is known about the use of antioxidants in the clinical treatment of vitiligo. To investigate
the specific use of antioxidants in the treatment of vitiligo and the possible reasons behind its …

Background Several treatment modalities are available for the treatment of vitiligo due to the
lack of a uniformly effective therapy. Topical latanoprost 0.005% is an effective topical …

Vitiligo is a chronic pigmentary condition and severely impacts patient quality of life (QoL). It
is an underrecognized burden for patients, healthcare systems, and society in Latin America …

Aim This study aimed to compare the efficacy and safety of excimer laser (EL)-based
combination regimens in improving repigmentation. Methods A comprehensive search was …

Melanocytes are highly specialized dendritic cells that synthesize and store melanin in
subcellular organelles called melanosomes, before transfer to keratinocytes. Melanin is a …

Objective: We explored the patterns of long non-coding RNA (lncRNA) expression in
peripheral blood mononuclear cells (PBMCs) from patients with non-segmental vitiligo …

Vitiligo is an autoimmune disease resulting in destruction of melanocytes which leads to
depigmented patches on the skin. An assessment of disease activity and/or stability is …